CD4-CD8 Ratio

"CD4-CD8 Ratio" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Ratio of T-LYMPHOCYTES that express the CD4 ANTIGEN to those that express the CD8 ANTIGEN. This value is commonly assessed in the diagnosis and staging of diseases affecting the IMMUNE SYSTEM including HIV INFECTIONS.

Descriptor ID

D016516

MeSH Number(s)

E01.370.225.500.195.107.595.500.150.160

E01.370.225.625.107.595.500.150.160

E05.200.500.195.107.595.500.150.160

E05.200.625.107.595.500.150.160

E05.242.195.107.595.500.150.160

G04.170.107.595.500.150.160

G09.188.105.595.500.150.160

G12.248

Concept/Terms

CD4-CD8 Ratio

Below are MeSH descriptors whose meaning is more general than "CD4-CD8 Ratio".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Cytological Techniques [E05.200.500]
Cell Count [E05.200.500.195]
Blood Cell Count [E05.200.500.195.107]
Leukocyte Count [E05.200.500.195.107.595]
Lymphocyte Count [E05.200.500.195.107.595.500]
CD4 Lymphocyte Count [E05.200.500.195.107.595.500.150]
CD4-CD8 Ratio [E05.200.500.195.107.595.500.150.160]
Biological Sciences [G]
Cell Physiological Phenomena [G04]
Cell Count [G04.170]
Blood Cell Count [G04.170.107]
Leukocyte Count [G04.170.107.595]
Lymphocyte Count [G04.170.107.595.500]
CD4 Lymphocyte Count [G04.170.107.595.500.150]
CD4-CD8 Ratio [G04.170.107.595.500.150.160]
Circulatory and Respiratory Physiological Phenomena [G09]
Blood Physiological Phenomena [G09.188]
Blood Cell Count [G09.188.105]
Leukocyte Count [G09.188.105.595]
Lymphocyte Count [G09.188.105.595.500]
CD4 Lymphocyte Count [G09.188.105.595.500.150]
CD4-CD8 Ratio [G09.188.105.595.500.150.160]
Immune System Phenomena [G12]
CD4-CD8 Ratio [G12.248]

Below are MeSH descriptors whose meaning is related to "CD4-CD8 Ratio".

Below are MeSH descriptors whose meaning is more specific than "CD4-CD8 Ratio".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "CD4-CD8 Ratio" by people in Harvard Catalyst Profiles by year, and whether "CD4-CD8 Ratio" was a major or minor topic of these publication.

Bar chart showing 73 publications over 27 distinct years, with a maximum of 6 publications in 1997 and 2000 and 2003

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	5	5
1995	0	3	3
1997	0	6	6
1998	0	3	3
1999	0	3	3
2000	0	6	6
2001	0	2	2
2002	0	1	1
2003	1	5	6
2004	0	2	2
2005	0	3	3
2006	1	1	2
2007	0	1	1
2008	0	2	2
2009	0	3	3
2010	0	3	3
2012	1	1	2
2014	0	1	1
2015	0	1	1
2016	2	1	3
2017	0	2	2
2018	0	2	2
2019	0	4	4
2020	0	2	2
2021	0	2	2
2022	0	2	2
2023	0	1	1

Below are the most recent publications written about "CD4-CD8 Ratio" by people in Profiles.

Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency. Front Immunol. 2023; 14:1183859.

View in: PubMed
Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events. EBioMedicine. 2022 Jun; 80:104072.

View in: PubMed
Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression. Sci Rep. 2022 02 14; 12(1):2437.

View in: PubMed
Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV. Lancet HIV. 2021 06; 8(6):e317-e318.

View in: PubMed
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes. EBioMedicine. 2021 Jan; 63:103175.

View in: PubMed
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. J Infect Dis. 2020 07 09; 222(Suppl 1):S8-S19.

View in: PubMed
Impact of first-line antiretroviral therapy regimens on the restoration of the CD4/CD8 ratio in the CNICS cohort. J Antimicrob Chemother. 2020 06 01; 75(6):1604-1610.

View in: PubMed
Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease. J Clin Invest. 2020 01 02; 130(1):507-522.

View in: PubMed
Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapy. AIDS. 2019 12 01; 33(15):2289-2298.

View in: PubMed
Very Early Initiation of Antiretroviral Therapy During Acute HIV Infection Is Associated With Normalized Levels of Immune Activation Markers in Cerebrospinal Fluid but Not in Plasma. J Infect Dis. 2019 11 06; 220(12):1885-1891.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

J Infect Dis
Clin Diagn Lab Immunol
AIDS
J Immunol
J Biol Regul Homeost Agents
PLoS One
Int Immunopharmacol
Clin Infect Dis
AIDS Res Ther
AIDS Res Hum Retroviruses